Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Related Articles by Review for PubMed (Select 12941918)

1.

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Lemiale F, Kong WP, Aky├╝rek LM, Ling X, Huang Y, Chakrabarti BK, Eckhaus M, Nabel GJ.

J Virol. 2003 Sep;77(18):10078-87.

2.

Virus-like particle and DNA-based candidate AIDS vaccines.

Yao Q, Bu Z, Vzorov A, Yang C, Compans RW.

Vaccine. 2003 Jan 30;21(7-8):638-43. Review.

PMID:
12531332
3.

Short communication: enhancement of immunogenicity of replication-defective adenovirus-based human immunodeficiency virus vaccines in rhesus monkeys.

Sun C, Zhang Y, Liu Y, Zhang M, Chen L.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):681-6. doi: 10.1089/AID.2010.0210. Epub 2011 Jan 8. Review.

PMID:
21083437
4.

Development of adenoviral vector-based mucosal vaccine against influenza.

Tutykhina IL, Logunov DY, Shcherbinin DN, Shmarov MM, Tukhvatulin AI, Naroditsky BS, Gintsburg AL.

J Mol Med (Berl). 2011 Apr;89(4):331-41. doi: 10.1007/s00109-010-0696-0. Epub 2010 Nov 21. Review.

PMID:
21104066
5.

Mucosal immune responses associated with polynucleotide vaccination.

Malone JG, Bergland PJ, Liljestrom P, Rhodes GH, Malone RW.

Behring Inst Mitt. 1997 Feb;(98):63-72. Review.

PMID:
9382771
6.

Vaginal immunization with recombinant gram-positive bacteria.

Medaglini D, Oggioni MR, Pozzi G.

Am J Reprod Immunol. 1998 Mar;39(3):199-208. Review.

PMID:
9526609
7.

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins.

Mooij P, Heeney JL.

Vaccine. 2001 Nov 12;20(3-4):304-21. Review.

PMID:
11672892
8.

Adenoviruses as vectors for delivering vaccines to mucosal surfaces.

Babiuk LA, Tikoo SK.

J Biotechnol. 2000 Sep 29;83(1-2):105-13. Review.

PMID:
11000466
9.

Development of nonhuman adenoviruses as vaccine vectors.

Bangari DS, Mittal SK.

Vaccine. 2006 Feb 13;24(7):849-62. Epub 2005 Sep 23. Review.

10.

Baculovirus as vaccine vectors.

Madhan S, Prabakaran M, Kwang J.

Curr Gene Ther. 2010 Jun;10(3):201-13. Review.

PMID:
20394572
11.

Viral vaccination via the mucosal routes.

Ogra PL, Fishaut M, Gallagher MR.

Rev Infect Dis. 1980 May-Jun;2(3):352-69. Review.

PMID:
6997965
12.

Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases.

Zhang J, Tarbet EB, Toro H, Tang DC.

Expert Rev Vaccines. 2011 Nov;10(11):1539-52. doi: 10.1586/erv.11.141. Review.

PMID:
22043954
13.

Effect of administration route on the biodistribution and shedding of replication-deficient HAdV-5: a qualitative modelling approach.

Tiesjema B, Hermsen HP, van Eijkeren JC, Brandon EF.

Curr Gene Ther. 2010 Apr;10(2):107-27. Review.

PMID:
20222861
14.

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Patterson LJ, Robert-Guroff M.

Expert Opin Biol Ther. 2008 Sep;8(9):1347-63. doi: 10.1517/14712598.8.9.1347 . Review.

15.

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.

Bramson JL, Wan YH.

Expert Opin Biol Ther. 2002 Jan;2(1):75-85. Review.

PMID:
11772342
16.
17.

New viral vectors for HIV vaccine delivery.

Cairns JS, Sarver N.

AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1501-8. Review. No abstract available.

PMID:
9840283
18.

Strategies to overcome host immunity to adenovirus vectors in vaccine development.

Thacker EE, Timares L, Matthews QL.

Expert Rev Vaccines. 2009 Jun;8(6):761-77. doi: 10.1586/erv.09.29. Review.

19.

Nasal delivery of epitope based vaccines.

Olszewska W, Steward MW.

Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):161-71. Review.

PMID:
11516787
20.

Replicating and non-replicating viral vectors for vaccine development.

Robert-Guroff M.

Curr Opin Biotechnol. 2007 Dec;18(6):546-56. Epub 2007 Dec 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk